FibroBiologics Inc. Common Stock

FBLG | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.41

+$0.05 (+3.68%)

Sep 22, 2026, 1:50 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q1 2022 Mar 30, 2022
Cash & Equivalents	3.52M	1.48M	4.89M	4.87M	8.85M	8.67M	13.99M	7.83M	5.97M	8.16M	9.16M	10.77M	11.38M	n/a	2.27M	407K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	48K	48K	48K	48K	48K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-407K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.34M	403K	n/a	n/a	n/a	18K	18K	18K	18K	18K	16K	121K	314K	n/a	330K	n/a
Total Current Assets	5.85M	2.91M	6.35M	5.24M	10.18M	9.33M	14.23M	8.2M	6.51M	8.92M	9.22M	10.91M	11.76M	2.27M	2.63M	407K
Property-Plant & Equipment	2.03M	2.99M	3.22M	3.46M	3.68M	2.1M	2.22M	2.27M	2.4M	2.48M	2.61M	2.39M	2.08M	n/a	2.2M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.08M	3.03M	3.27M	3.5M	3.73M	2.1M	2.22M	2.27M	2.4M	2.48M	2.61M	2.39M	2.08M	-2.27M	2.2M	-407K
Total Assets	7.93M	5.94M	9.62M	8.74M	13.91M	11.43M	16.45M	10.47M	8.91M	11.4M	11.82M	13.3M	13.84M	n/a	4.82M	n/a
Account Payables	n/a	850K	945K	1.07M	1.8M	1.42M	2.7M	1.18M	1.21M	814K	1.44M	820K	598K	n/a	758K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	258K	246K	n/a	5.22M	8.69M	5.84M	9.17M	115K	287K	459K	362K	353K	n/a	n/a	5.45M	n/a
Other Current Liabilities	1.96M	10K	108K	437K	470K	543K	460K	4.99M	8.26M	12.34M	7.24M	206K	n/a	n/a	538K	n/a
Total Current Liabilities	2.21M	1.83M	1.76M	6.72M	10.96M	8.21M	12.73M	6.68M	10.13M	13.99M	9.18M	1.31M	942K	n/a	7.07M	n/a
Long-Term Debt	1.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.29M
Total Long-Term Liabilities	1.08M	1.51M	1.7M	1.9M	2.08M	865K	984K	1.06M	1.17M	1.28M	1.39M	1.45M	1.55M	4M	1.75M	1.29M
Total Liabilities	3.29M	3.34M	3.46M	8.62M	13.05M	9.08M	13.71M	7.73M	11.3M	15.26M	10.57M	2.76M	2.49M	4M	8.82M	1.29M
Total Debt	1.34M	2.48M	2.41M	7.11M	10.78M	7.12M	10.55M	1.56M	1.84M	2.11M	1.75M	1.8M	1.89M	n/a	7.52M	n/a
Book Value	4.64M	2.6M	6.16M	125K	860K	2.35M	2.74M	2.74M	-2.39M	-3.86M	1.25M	10.54M	11.35M	-4M	-4M	-1.29M
Book Value Per Share	0.74	1.16	2.76	0.06	0.45	1.28	1.57	1.63	-1.46	-2.48	0.79	6.49	6.99	-2.46	-2.63	-0.85
Common Stock	1K	1K	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	1K	1K	n/a	1K	n/a
Retained Earnings	-63.28M	-59.16M	-54.16M	-50.92M	-45.14M	-40.48M	-35.52M	-32.42M	-31.92M	-32.82M	-24.36M	-14.64M	-12.45M	n/a	-7.87M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.46M	-1.29M
Shareholders Equity	4.64M	2.6M	6.16M	125K	860K	2.35M	2.74M	2.74M	-2.39M	-3.86M	1.25M	10.54M	11.35M	-4M	-4M	-1.29M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a